TW355710B - Pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles the invention relates to the process of preparing pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles useful for relieving memory dysfunction and treating depression - Google Patents

Pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles the invention relates to the process of preparing pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles useful for relieving memory dysfunction and treating depression

Info

Publication number
TW355710B
TW355710B TW085106396A TW85106396A TW355710B TW 355710 B TW355710 B TW 355710B TW 085106396 A TW085106396 A TW 085106396A TW 85106396 A TW85106396 A TW 85106396A TW 355710 B TW355710 B TW 355710B
Authority
TW
Taiwan
Prior art keywords
pyridiniminyl
benzisoxazoles
benzisothiazoles
preparing
useful
Prior art date
Application number
TW085106396A
Other languages
English (en)
Inventor
David M Fink
Barbara E Kurys
Gregory M Shutske
Iv John D Tomer
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of TW355710B publication Critical patent/TW355710B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
TW085106396A 1995-06-06 1996-05-29 Pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles the invention relates to the process of preparing pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles useful for relieving memory dysfunction and treating depression TW355710B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46602195A 1995-06-06 1995-06-06
US08/637,091 US5668154A (en) 1995-06-06 1996-05-02 Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles

Publications (1)

Publication Number Publication Date
TW355710B true TW355710B (en) 1999-04-11

Family

ID=23850131

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085106396A TW355710B (en) 1995-06-06 1996-05-29 Pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles the invention relates to the process of preparing pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles useful for relieving memory dysfunction and treating depression

Country Status (17)

Country Link
US (3) US5668154A (zh)
EP (1) EP0848713B1 (zh)
KR (1) KR100309215B1 (zh)
AR (1) AR002204A1 (zh)
AT (1) ATE197153T1 (zh)
AU (1) AU708843B2 (zh)
CA (1) CA2224171A1 (zh)
DE (1) DE69610778T2 (zh)
DK (1) DK0848713T3 (zh)
ES (1) ES2153584T3 (zh)
GR (1) GR3035249T3 (zh)
HU (1) HUP9802571A3 (zh)
NO (1) NO975682L (zh)
NZ (1) NZ308831A (zh)
PT (1) PT848713E (zh)
TW (1) TW355710B (zh)
ZA (1) ZA964565B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
GT199900185A (es) 1998-11-06 2001-04-18 Novedosa pirimidin-4-enamina como fungicida.
US6123554A (en) * 1999-05-28 2000-09-26 Berg Technology, Inc. Connector cover with board stiffener
US9907751B2 (en) * 2016-03-10 2018-03-06 RxOMEG Therapeutics LLC Composition and method of use of colchicine oral liquid
US10226423B1 (en) 2017-12-20 2019-03-12 RxOMEG Therapeutics LLC Colchicine drug-to-drug interactions
CN110117278B (zh) * 2018-02-07 2022-07-19 石家庄以岭药业股份有限公司 烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
WO2023083445A1 (en) 2021-11-10 2023-05-19 Symrise Ag Compositions comprising trpm8 agonistic cooling agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds

Also Published As

Publication number Publication date
KR100309215B1 (ko) 2001-12-28
AU5867796A (en) 1996-12-24
US5668154A (en) 1997-09-16
EP0848713A1 (en) 1998-06-24
NZ308831A (en) 1998-11-25
AR002204A1 (es) 1998-01-07
HUP9802571A2 (hu) 1999-08-30
US5728717A (en) 1998-03-17
NO975682D0 (no) 1997-12-05
NO975682L (no) 1998-02-05
DK0848713T3 (da) 2000-12-18
AU708843B2 (en) 1999-08-12
MX9709450A (es) 1998-06-28
GR3035249T3 (en) 2001-04-30
ATE197153T1 (de) 2000-11-15
EP0848713B1 (en) 2000-10-25
KR19990022265A (ko) 1999-03-25
CA2224171A1 (en) 1996-12-12
US5948798A (en) 1999-09-07
ES2153584T3 (es) 2001-03-01
DE69610778D1 (de) 2000-11-30
HUP9802571A3 (en) 1999-11-29
PT848713E (pt) 2001-02-28
ZA964565B (en) 1996-12-12
DE69610778T2 (de) 2001-06-13

Similar Documents

Publication Publication Date Title
ZA842185B (en) New n-aryl-n'-cycloalkylalkanoyl-piperazine and process for the production thereof
ZA9610418B (en) Phenylimidazolidines containing in particular a nitrooxy or carbonyloxy radical, preparation process and intermediates, use as medicaments, new uses and pharmaceutical compositions.
ZA955760B (en) Sulfonamide derivatives of azolones
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
TW355710B (en) Pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles the invention relates to the process of preparing pyridiniminyl-1,2-benzisoxazoles and benzisothiazoles useful for relieving memory dysfunction and treating depression
PH24139A (en) Method of treating anxiety with tetrahydrobenzy(c,d)indole-6-carboxamides
GR74293B (zh)
TW360654B (en) Oxazolidinone derivatives, their preparation and therapeutical use
HK1042697A1 (en) Process to prepare cyclic-sulfur fluorine containing oxazolidinones
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
ZA917141B (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and their use as medicaments
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
DE69203194T2 (de) Thiazolidine-2,4-dione für die Behandlung der Hypertonie.
DK0698601T3 (da) Fremgangsmåde til fremstilling af (-)-N-methyl-N-4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorphenyl)butylbenzami
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders
MX9708031A (es) Sales de 3-fenil-1,4-dialquil-1,2,4-triazolio y su uso como antidepresivos.
MX9604610A (es) Derivados ester y carbamato de azolonas anti- helicobacter